tradingkey.logo
搜索

Xtant Medical Holdings Inc

XTNT
添加自选
0.456USD
-0.014-2.91%
收盘 05/15, 16:00美东报价延迟15分钟
63.95M总市值
34.64市盈率 TTM

Xtant Medical Holdings Inc

0.456
-0.014-2.91%

关于 Xtant Medical Holdings Inc 公司

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.

Xtant Medical Holdings Inc简介

公司代码XTNT
公司名称Xtant Medical Holdings Inc
上市日期Jun 30, 2010
CEOBrowne (Sean E)
员工数量217
证券类型Ordinary Share
年结日Jun 30
公司地址664 Cruiser Lane
城市BELGRADE
上市交易所NASDAQ OMX – NASDAQ Basic Amex
国家United States of America
邮编59714
电话14063880480
网址https://xtantmedical.com/
公司代码XTNT
上市日期Jun 30, 2010
CEOBrowne (Sean E)

Xtant Medical Holdings Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
6.96M
-7.95%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
755.89K
-20.93%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
370.27K
-53.11%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
--
Mr. Mark A. Schallenberger
Mr. Mark A. Schallenberger
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jonn R. Beeson
Mr. Jonn R. Beeson
Independent Director
Independent Director
--
--
Ms. Lori D. Mitchell-Keller
Ms. Lori D. Mitchell-Keller
Independent Director
Independent Director
--
--
Mr. Tyler P. Lipschultz
Mr. Tyler P. Lipschultz
Director
Director
--
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
--
--
Mr. Sean E. Browne
Mr. Sean E. Browne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
6.96M
-7.95%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
755.89K
-20.93%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
370.27K
-53.11%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
--
Mr. Mark A. Schallenberger
Mr. Mark A. Schallenberger
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jonn R. Beeson
Mr. Jonn R. Beeson
Independent Director
Independent Director
--
--

收入明细

单位: USD更新时间: 4月6日 周一
单位: USD更新时间: 4月6日 周一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Orthobiologics
72.89M
54.43%
Spinal implant
42.31M
31.59%
License revenue
18.72M
13.98%
地区USD
名称
营收
占比
United States
122.45M
91.43%
Rest of World
11.48M
8.57%
业务
地区
业务USD
名称
营收
占比
Orthobiologics
72.89M
54.43%
Spinal implant
42.31M
31.59%
License revenue
18.72M
13.98%

股东统计

更新时间: 5月10日 周日
更新时间: 5月10日 周日
持股股东
股东类型
持股股东
持股股东
占比
Nantahala Capital Management, LLC
48.83%
Lytton (Laurence W)
5.50%
Vizirgianakis (Stavros G)
4.97%
AWM Investment Company, Inc.
4.71%
Vanguard Capital Management, LLC
1.44%
其他
34.56%
持股股东
持股股东
占比
Nantahala Capital Management, LLC
48.83%
Lytton (Laurence W)
5.50%
Vizirgianakis (Stavros G)
4.97%
AWM Investment Company, Inc.
4.71%
Vanguard Capital Management, LLC
1.44%
其他
34.56%
股东类型
持股股东
占比
Hedge Fund
49.89%
Individual Investor
13.86%
Investment Advisor/Hedge Fund
5.61%
Investment Advisor
2.41%
Research Firm
0.03%
其他
28.20%

机构持股

更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q4
41
80.10M
114.61%
--
2026Q1
63
83.43M
59.56%
-78.98M
2025Q4
60
79.98M
57.13%
-82.26M
2025Q3
58
80.07M
57.19%
-75.11M
2025Q2
66
93.42M
67.06%
-16.04M
2025Q1
66
107.33M
77.15%
-2.25M
2024Q4
65
107.45M
77.30%
-1.32M
2024Q3
60
109.08M
78.63%
+8.43M
2024Q2
61
99.68M
76.50%
-1.69M
2024Q1
63
100.56M
77.45%
+777.79K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Nantahala Capital Management, LLC
68.39M
48.85%
--
--
Dec 31, 2025
Lytton (Laurence W)
7.70M
5.5%
-1.76M
-18.61%
Dec 31, 2025
Vizirgianakis (Stavros G)
7.52M
5.37%
+553.80K
+7.95%
Nov 15, 2025
AWM Investment Company, Inc.
6.59M
4.71%
--
--
Dec 31, 2025
Browne (Sean E.)
1.94M
1.39%
+394.94K
+25.57%
Nov 15, 2025
Beeson (Jonn R.)
1.53M
1.09%
+158.23K
+11.51%
Nov 15, 2025
Renaissance Technologies LLC
919.86K
0.66%
+205.94K
+28.85%
Dec 31, 2025
Bakewell (John K)
914.12K
0.65%
+158.23K
+20.93%
Nov 15, 2025
Geode Capital Management, L.L.C.
491.95K
0.35%
--
--
Dec 31, 2025
查看更多

持股ETF

机构名称
占比
暂无数据

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI